Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...

Johnson & Johnson said it will invest more than $55 billion in the US as President Donald Trump wields the threat of tariffs ...

Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training ...

Merck & Co/MSD has agreed to buy Pandion for ... and is vying to come to market along with other IL-2-based therapies, notably Eli Lilly and Nektar Therapeutics’ phase 2 candidate LY3471851 ...

Merck said on Tuesday it has opened a $1-billion ... to discuss industry concerns such as tariffs on drug imports. Eli Lilly has since announced plans to invest at least $27 billion to build ...

Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and ...

Merck and Pfizer are to take on the crowded SGLT2 ... including AstraZeneca’s Farxiga and Janssen's Invokana. Most notable is Eli Lilly/Boehringer’s Jardiance, which has broken new ground ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

Pharmaceutical giants such as J&J, Merck, and Eli Lilly are embracing AI and prioritizing upskilling. They hope that training thousands of employees on generative AI will boost productivity in ...